M-tron Industries, Inc. (MPTI)

M-tron Industries, Inc. (MPTI) is a manufacturer specializing in engineered electronic and electro-mechanical components, including connectors, switches, and instrumentation products. The company serves various markets such as medical, industrial, aerospace, and military, providing custom and standard solutions to meet diverse customer needs.

🚫 M-tron Industries, Inc. does not pay dividends

Company News

M-tron Industries Sales Jump 12 Percent
The Motley Fool • Jesterai • August 13, 2025

M-tron Industries reported Q2 2025 earnings with 12.5% revenue growth but missed EPS expectations due to margin compression from tariffs and higher operating costs. The company maintains a strong backlog and continues to focus on high-reliability markets like aerospace and defense.

M-tron Industries, Inc. (MPTI) Stock Moves -0.55%: What You Should Know
Zacks Investment Research • Zacks Equity Research • August 2, 2024

M-tron Industries, Inc. (MPTI) stock saw a 0.55% decline in the latest trading session, underperforming the broader market. Analysts and investors will be closely watching the company's upcoming earnings report, which is expected to show year-over-year growth.

Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Benzinga • Lisa Levin • October 12, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. DICE Therapeutics, Inc. (NASDAQ: DICE) shares gained 62.3% to close at $40.00 after the company announced topline data from its Phase 1 clinical trial of DC-806. Clinical proof-of-concept in psoriasis patients achieved with a mean percentage reduction in PASI from baseline at 4 weeks of 43.7% in the high dose group. Immunic, Inc. (NASDAQ: IMUX) surged 51.8% to close at $9.41. Immunic recently announced $60 million oversubscribed private placement equity financing. ForgeRock, Inc. (NYSE: FORG) rose 48.6% to close at $22.52 after the company announced it will be acquired by Thoma Bravo for $2.3 billion. Laser Photonics Corporation (NASDAQ: LASE) gained 44.4% to close at $2.70 after the company announced it received an order from the U.S. Navy for delivery this month of an LPC-1000CTH CleanTech Laser Blasting System with an integrated water chiller for submarine MRO. scPharmaceuticals Inc. (NASDAQ: SCPH) gained 39.3% to close at $5.60. SVB Leerink upgraded scPharmaceuticals from Market Perform to Outperform and raised the price target from $6 to $11. Oblong, Inc. (NASDAQ: OBLG) rose 38.6% to close at $0.2340. AMTD Digital Inc. (NYSE: HKD) gained 35.3% to settle at $41.15. Meiwu Technology Company Limited (NASDAQ: WNW) climbed 33.7% to close at $1.17. Agrify Corporation (NASDAQ: AGFY) gained 32.6% to close at $0.5074. Mercurity Fintech Holding Inc. (NASDAQ: MFH) surged 30.8% to close at $1.06. Bright Health Group, Inc. (NYSE: BHG) gained 28.6% to close at $1.17. NantHealth, Inc. (NASDAQ: NH) surged 22.9% to close at $0.2899. Lottery.com Inc. (NASDAQ: LTRY) climbed 21.3% to close at $0.3021. Innovative Eyewear, Inc. (NASDAQ: LUCY) gained 20.4% to close at $2.60. Minerva Neurosciences, Inc. (NASDAQ: NERV) rose 19% to settle at $12.46. Braskem S.A. (NYSE: BAK) shares climbed 18.8% to close at $12.76 following a report suggesting Apollo has made a new offer for the company. Mawson Infrastructure Group, Inc. (NASDAQ: MIGI) gained 18% to close at $0.5538. Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) rose 16.4% to close at $0.1464. Adamis Pharmaceuticals recently initiated a process to explore a range of strategic and financing alternatives. Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) gained 16.3% to close at $3.22. Greenbrook TMS Inc. (NASDAQ: GBNH) climbed 14.9% to close at $3.32. Albireo Pharma, Inc. (NASDAQ: ALBO) shares gained 14.4% to close at $23.42 after the company announced topline results from the Phase 3 of Bylvay in Alagille syndrome showed highly statistically significant improvement in pruritus primary endpoint. Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) rose 14.3% to close at $8.00. UBS initiated coverage on Rani Therapeutics with a ...